Massive $1.5B investment in manufacturing widens Eli Lilly's footprint in Ireland and North Carolina
What do North Carolina and Ireland have in common? A tradition of friendly people, a deep appreciation of breweries, and now, new Eli Lilly manufacturing sites, set to hire 900 people.
Indianapolis-based Eli Lilly will pump almost $1.5 billion into the two new manufacturing facilities, the company announced on Friday. The short-term focus of these plants will be to bolster diabetes and cancer products, while the sites will take on Alzheimer’s and obesity medications in the long run.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters